Comparison of the effect of terlipressin and albumin on arterial blood volume in patients with cirrhosis and tense ascites treated by paracentesis: a randomised pilot study

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Gut

• Publication date

  2002-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/gut.50.1.90PMID 11772973PMCID PMC1773081
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Albumin Infusion for Spontaneous Bacterial Peritonitis.

  2022cited by this paper
• Total therapeutic paracentesis (TTP) with and without intravenous albumin in the treatment of cirrhotic tense ascites: a randomized controlled trial.

  2008cited by this paper
• Management of adult patients with ascites due to cirrhosis

  2004cited by this paper
• Albumin infusion for spontaneous bacterial peritonitis.

  1999cited by this paper
• Human albumin administration in critically ill patients: systematic review of randomised controlled trials.

  1998cited by this paper
• Beneficial effects of the 2‐day administration of terlipressin in patients with cirrhosis and hepatorenal syndrome

  1998cited by this paper
• Beneficial effects of the 2-day administration of terlipressin in patients with cirrhosis and hepatorenal syndrome

  1998cited by this paper
• Management of adult patients with ascites caused by cirrhosis

  1998cited by this paper
• Hemodynamic changes in patients developing effective hypovolemia after total paracentesis.

  1998cited by this paper
• Natriuretic response to the combination of atrial natriuretic peptide and terlipressin in patients with cirrhosis and refractory ascites.

  1997cited by this paper
• Paracentesis-induced circulatory dysfunction: mechanism and effect on hepatic hemodynamics in cirrhosis.

  1997cited by this paper
• Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis.

  1996cited by this paper
• Transjugular intrahepatic portosystemic shunts: Comparison with paracentesis in patients with cirrhosis and refractory ascites: A randomized trial

  1996cited by this paper
• Transjugular intrahepatic portosystemic shunts: comparison with paracentesis in patients with cirrhosis and refractory ascites: a randomized trial. French Group of Clinicians and a Group of Biologists.

  1996cited by this paper
• Beneficial effects of intravenous albumin infusion on the hemodynamic and humoral changes after total paracentesis

  1995cited by this paper
• Time course of circulatory and humoral effects of rapid total paracentesis in cirrhotic patients with tense, refractory ascites.

  1994cited by this paper
• Total paracentesis in non‐alcoholic cirrhotics with massive ascites: Mid‐term effects on systemic and hepatic haemodynamics and renal function

  1994cited by this paper
• Assessment of the renin-angiotensin system in cirrhotic patients. Comparison between plasma renin activity and direct measurement of immunoreactive renin.

  1992cited by this paper
• Assessment of the renin-angiotensin system in cirrhotic patients. Comparison between plasma renin activity and direct measurement of immunoreactive renin.

  1992cited by this paper
• Single, total paracentesis for tense ascites: Sequential hemodynamic changes and right atrial size

  1990cited by this paper
• Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis.

  1988cited by this paper
• Large‐volume paracentesis in nonedematous patients with tense ascites: Its effect on intravascular volume

  1988cited by this paper
• Effects of therapeutic paracentesis on systemic and hepatic hemodynamics and on renal and hormonal function

  1987cited by this paper
• Repeated paracentesis and i.v. albumin infusion to treat 'tense' ascites in cirrhotic patients. A safe alternative therapy.

  1987cited by this paper
• Paracentesis versus diuretics in the treatment of cirrhotics with tense ascites.

  1985cited by this paper
• The effect of large volume paracentesis on plasma volume—A cause of hypovolemia?

  1985cited by this paper

• Addition of midodrine to albumin reduces the incidence of complications of large-volume paracentesis: an RCT comparing midodrine, terlipressin, and albumin

  2025influential citation
• Human albumin infusion for reducing hyponatremia and circulatory dysfunction in liver cirrhosis: A meta-analysis update

  2025cites this paper
• From Pathophysiology to Practice: Evolving Pharmacological Therapies, Clinical Complications, and Pharmacogenetic Considerations in Portal Hypertension

  2025cites this paper
• Pathophysiology of Hepatorenal Syndrome.

  2024cites this paper
• Subcutaneous therapy for portal hypertension: PHIN-214, a partial vasopressin receptor 1A agonist

  2024cites this paper
• Terlipressin in the management of liver disease

  2023cites this paper
• Midodrine versus Albumin to Prevent Paracentesis Induced Circulatory Dysfunction in Acute on Chronic Liver Failure Patients in the Outpatient Clinic-a Randomized Controlled Trial.

  2023cites this paper
• Asia–Pacific association for study of liver guidelines on management of ascites in liver disease

  2023cites this paper
• Use of human albumin infusion in cirrhotic patients: a systematic review and meta-analysis of randomized controlled trials

  2022cites this paper
• Practice guidance for the use of terlipressin for liver cirrhosis–related complications

  2022cites this paper
• Use of Human Albumin Administration for the Prevention and Treatment of Hyponatremia in Patients with Liver Cirrhosis: A Systematic Review and Meta-Analysis

  2022cites this paper
• Vasoactive drugs for adults with cirrhosis and large ascites treated with paracentesis

  2021cites this paper
• ACR Appropriateness Criteria® Radiologic Management of Portal Hypertension.

  2021cites this paper
• Safety and Efficacy of Human Serum Albumin Treatment in Patients with Cirrhotic Ascites Undergoing Paracentesis: A Systematic Review and Meta-Analysis.

  2021cites this paper
• Management of Flood syndrome: What can we do better?

  2021cites this paper
• The Use of Plasma Expanders in Preventing Paracentesis-Induced Circulatory Dysfunction: A Brief Review

  2020cites this paper
• High efficacy of low-dose albumin infusion in the prevention of paracentesis-induced circulatory dysfunction

  2020cites this paper
• Terlipressin has stood the test of time: Clinical overview in 2020 and future perspectives

  2020cites this paper
• Effect of Terlipressin on Renal Function in Liver Cirrhosis With Ascites: A Pilot Study.

  2020cites this paper
• Prevention of paracentesis‐induced circulatory dysfunction—A systematic review and network meta‐analysis

  2020cites this paper
• Albumin Administration is Efficacious in the Management of Patients with Cirrhosis: A Systematic Review of the Literature

  2020cites this paper
• Pathophysiology and Prevention of Paracentesis-induced Circulatory Dysfunction: A Concise Review

  2020influential citation
• Role of Terlipressin in Cirrhotic Patients with Ascites and without Hepatorenal Syndrome: A Systematic Review of Current Evidence

  2020cites this paper
• Paracentesis-induced circulatory dysfunction: are there albumin alternatives?

  2020cites this paper
• Effect of alpha agonists on the prevention of postparacentesis circulatory dysfunction in patients with refractory or recurrent ascites: a meta-analysis

  2020cites this paper
• RADIOLOGIC MANAGEMENT OF PORTAL HYPERTENSION on Interventional Radiology and Vascular

  2020cites this paper
• Ascites and Hepatorenal Syndrome.

  2019cites this paper
• Who Needs a Paracentesis? How Do I Optimize Safety? How Do I Interpret the Results?

  2019cites this paper
• Reappraising the spectrum of AKI and hepatorenal syndrome in patients with cirrhosis

  2019cites this paper
• Effects of terlipressin infusion during hepatobiliary surgery on systemic and splanchnic haemodynamics, renal function and blood loss: a double-blind, randomized clinical trial

  2019cites this paper
• Oral midodrine is comparable to albumin infusion in cirrhotic patients with refractory ascites undergoing large-volume paracentesis: results of a pilot study

  2019cites this paper
• Refractory Ascites in Liver Cirrhosis

  2019cites this paper
• An update on the pathogenesis and clinical management of cirrhosis with refractory ascites

  2018cites this paper
• Treatment for ascites in adults with decompensated liver cirrhosis: a network meta-analysis.

  2018cites this paper
• New Insights About Albumin and Liver Disease.

  2018cites this paper
• Beneficial and harmful effects of nonselective beta blockade on acute kidney injury in liver transplant candidates

  2017cites this paper
• Effects of Different Environmental Factors and Virulence Factors, dupA and iceA Genes, of Helicobacter Pylori on Peptic Ulcer

  2017cites this paper
• Non-pharmacological Treatment of Ascites

  2017cites this paper
• Albumin Use in Patients With Cirrhosis in France: Results of the "ALBU-LIVE" Survey: A Case for Better EASL Guidelines Diffusion and/or Revision.

  2017cites this paper
• Effect of Midodrine in Patients with Liver Cirrhosis and Refractory Ascites

  2017cites this paper
• Insufficient evidence of benefit regarding mortality due to albumin substitution in HCC‐free cirrhotic patients undergoing large volume paracentesis

  2017cites this paper
• Albumin Use in Patients With Cirrhosis in France: Results of the "ALBU-LIVE" Survey: A Case for Better EASL Guidelines Diffusion and/or Revision.

  2017cites this paper
• Challenges in Renal Failure Treatment Before Liver Transplant.

  2017cites this paper
• Acute kidney injury in the ICU: from injury to recovery: reports from the 5th Paris International Conference

  2017cites this paper
• Midodrine and tolvaptan in patients with cirrhosis and refractory or recurrent ascites: a randomised pilot study

  2017cites this paper
• Role of albumin in cirrhosis: from a hospitalist’s perspective

  2017cites this paper
• Effect of different therapeutic modalities on systemic, renal, and hepatic hemodynamics and short-term outcomes in cirrhotic patients with spontaneous bacterial peritonitis

  2016cites this paper
• AISF-SIMTI position paper: the appropriate use of albumin in patients with liver cirrhosis.

  2016cites this paper
• Abdominal Circulatory Interactions.

  2016cites this paper
• AISF-SIMTI Position Paper: The appropriate use of albumin in patients with liver cirrhosis.

  2016cites this paper
• Effects of midodrine in patients with ascites due to cirrhosis: Systematic review and meta‐analysis

  2016cites this paper
• Midodrine and tolvaptan in patients with cirrhosis and refractory or recurrent ascites : a randomized pilot study ( Short title – Midodrine and tolvaptan in refractory cirrhotic ascites )

  2016cites this paper
• Management of refractory ascites in cirrhosis: Are we out of date?

  2016cites this paper
• ISF-SIMTI Position Paper : The appropriate use of albumin in patients ith liver cirrhosis talian Association for the Study of the Liver ( AISF ) talian Society of Transfusion

  2016cites this paper
• The haemodynamic effects of the perioperative terlipressin infusion in living donor liver transplantation: A randomised controlled study

  2015cites this paper
• The Effect of inotropes and vasopressors on mortality: a meta-analysis of randomized clinical trials.

  2015cites this paper
• The impact of paracentesis flow rate in patients with liver cirrhosis on the development of paracentesis induced circulatory dysfunction

  2015cites this paper
• Post‐paracentesis circulatory derangements are related to monocyte activation

  2014cites this paper
• Comparison of Midodrine and Albumin in the Prevention of Paracentesis-induced Circulatory Dysfunction in Cirrhotic Patients: A Randomized Pilot Study

  2014cites this paper
• Beta-blockers in liver cirrhosis

  2014cites this paper
• MOGUĆE BUBREŽNE BOLESTI NAKON TRANSPLANTACIJE JETRE

  2014influential citation
• Liver Intensive Care

  2014cites this paper
• Review article: advances in the management of patients with cirrhosis and portal hypertension‐related renal dysfunction

  2014cites this paper
• Paracentesis-Induced Circulatory Dysfunction: A Primer for the Interventional Radiologist

  2014cites this paper
• Midodrine and Clonidine in Patients With Cirrhosis and Refractory or Recurrent Ascites: A Randomized Pilot Study

  2013cites this paper
• Prevention of paracentesis-induced circulatory dysfunction: could we use other albumin alternatives?

  2013cites this paper
• Management of ascites in patients with liver cirrhosis: Recent evidence and controversies

  2013cites this paper
• Noradrenaline vs terlipressin in the treatment of type 2 hepatorenal syndrome: a randomized pilot study

  2013cites this paper
• Hepatorenal Syndrome and Novel Advances in its Management

  2013cites this paper
• Human serum albumin: from bench to bedside.

  2012cites this paper
• Perioperative Assessment of Terlipressin Infusion during Living Donor Liver Transplantation

  2012cites this paper
• Kidneys in chronic liver diseases.

  2012cites this paper
• Management of ascites in cirrhosis

  2012cites this paper
• The combination of octreotide and midodrine is not superior to albumin in preventing recurrence of ascites after large-volume paracentesis.

  2012cites this paper
• Terlipressin Resolves Ascites of Cirrhotic Rats through Downregulation of Aquaporin 2

  2012cites this paper
• Midodrine in patients with cirrhosis and refractory or recurrent ascites: a randomized pilot study.

  2012cites this paper
• Management of refractory ascites.

  2012cites this paper
• Chapter 23 – Perioperative critical care in hepatopancreatobiliary patients

  2012cites this paper
• Albumin infusion in patients undergoing large‐volume paracentesis: A meta‐analysis of randomized trials

  2012cites this paper
• Treatment of ascites and spontaneous bacterial peritonitis - part I.

  2012cites this paper
• Beta-blockers cause paracentesis-induced circulatory dysfunction in patients with cirrhosis and refractory ascites: a cross-over study.

  2011cites this paper
• Prevention of paracentesis-induced circulatory dysfunction in cirrhosis: standard vs half albumin doses. A prospective, randomized, unblinded pilot study.

  2011cites this paper
• Large-Volume Paracentesis: Which Plasma Expander?

  2011cites this paper
• Terlipressin for Hepatorenal Syndrome: Novel Strategies and Future Perspectives

  2011cites this paper
• Balancing volume resuscitation and ascites management in cirrhosis

  2010cites this paper
• Deleterious effects of beta‐blockers on survival in patients with cirrhosis and refractory ascites

  2010cites this paper
• Refractory ascites: pathogenesis, definition and therapy of a severe complication in patients with cirrhosis

  2010cites this paper
• Predictors of large volume paracantesis induced circulatory dysfunction in patients with massive hepatic ascites

  2010cites this paper
• Paracentesis evacuante en pacientes cirróticos con ascitis a tensión: revisión del tema

  2010cites this paper
• The Hong Kong Medical Diary

  2010cites this paper
• American Thoracic Society Documents An Official ATS/ERS/ESICM/SCCM/SRLF Statement: Prevention and Management of Acute Renal Failure in the ICU Patient An International Consensus Conference in Intensive Care Medicine

  2010cites this paper
• An Official ATS/ERS/ESICM/SCCM/SRLF Statement: Prevention and Management of Acute Renal Failure in the ICU Patient: an international consensus conference in intensive care medicine.

  2010cites this paper
• Ascites: Pathogenesis and therapeutic principles

  2009cites this paper
• Management and Treatment of Patients With Cirrhosis and Portal Hypertension: Recommendations From the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program

  2009cites this paper
• Management of Ascites Dr

  2009cites this paper
• Management of renal dysfunction in the liver transplant recipient

  2009cites this paper
• Evaluation and management of patients with refractory ascites.

  2009cites this paper
• 6 Portale hypertensie

  2009cites this paper
• Avances en el tratamiento de la cirrosis hepática. Aplicaciones a la práctica clínica

  2009cites this paper
• Review: Vasoconstrictors for the treatment of portal hypertension

  2009cites this paper